Literature DB >> 11057355

A forced choice comfort study of olopatadine hydrochloride 0.1% versus ketotifen fumarate 0.05%.

M N Artal1, J D Luna, M Discepola.   

Abstract

PURPOSE: To compare the ocular comfort of two ophthalmic anti-allergic agents: olopatadine hydrochloride 0.1% and ketotifen fumarate 0.05%. SUBJECTS AND METHODS: In a double-masked, multi-centered, randomized trial, 80 subjects were asked to make a 'forced choice' based on ocular comfort between one drop of olopatadine hydrochloride 0.1% instilled in one eye and one drop of ketotifen fumarate 0.05% instilled in the contralateral eye. At one site, the incidence of adverse reactions was also reported.
RESULTS: All subjects (100%) selected olopatadine as the more comfortable formulation. One site (n = 35) reported a 49% incidence of moderate burning and a 49% incidence of mild burning after ketotifen instillation. One subject (2% of population) at this site experienced no ocular discomfort with ketotifen. There were no reports of discomfort associated with olopatadine instillation.
CONCLUSION: Olopatadine is a more comfortable ophthalmic preparation than ketotifen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11057355     DOI: 10.1034/j.1600-0420.2000.078s230064.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand Suppl        ISSN: 1395-3931


  10 in total

1.  Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.

Authors:  Manabu Tashiro; Hideki Mochizuki; Yumiko Sakurada; Kenji Ishii; Keiichi Oda; Yuichi Kimura; Toru Sasaki; Kiichi Ishiwata; Kazuhiko Yanai
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

Review 2.  Ocular allergy in pediatric practice.

Authors:  Mark B Abelson; David Granet
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

Review 3.  A review of the use of olopatadine in allergic conjunctivitis.

Authors:  James I McGill
Journal:  Int Ophthalmol       Date:  2004-05       Impact factor: 2.031

Review 4.  Ocular allergy guidelines: a practical treatment algorithm.

Authors:  Leonard Bielory
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management.

Authors:  Stacey Ackerman; Lisa M Smith; Paulo J Gomes
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

6.  Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops.

Authors:  Eiichi Uchio
Journal:  Clin Ophthalmol       Date:  2008-09

7.  Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model.

Authors:  Gail Torkildsen; Abhijit Narvekar; Mark Bergmann
Journal:  Clin Ophthalmol       Date:  2015-09-14

8.  Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference.

Authors:  Craig F McCabe; Shannon E McCabe
Journal:  Clin Ophthalmol       Date:  2012-10-29

Review 9.  Ocular allergy treatment comparisons: azelastine and olopatadine.

Authors:  Leonard Bielory; Praveen Buddiga; Stephen Bigelson
Journal:  Curr Allergy Asthma Rep       Date:  2004-07       Impact factor: 4.919

10.  Topical Olopatadine Hydrochloride versus Ketotifen Fumarate for Allergic Conjunctivitis.

Authors:  Dharmistha Patel; N Sarala; Narendra Panduranga Datti
Journal:  J Ophthalmic Vis Res       Date:  2018 Apr-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.